The best indicator for Align Technology (ALGN)
We backtested 20 indicators across daily, weekly and hourly charts on real Align Technology (ALGN) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
RSI Trend (>50)
On the weekly chart, this is the strongest risk-adjusted edge we found for Align Technology (ALGN) over ~25.4 years — beating buy-and-hold by 3.2% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | RSI Trend (>50) ✓ | Weekly | 13.4% | 0.52 | -62.8% | 45.5% | 55 | 3.2% |
| 2 | ADX / DMI ✓ | Weekly | 13.5% | 0.52 | -52.2% | 55.9% | 34 | 3.3% |
| 3 | EMA 20/50 Cross ✓ | Daily | 12.5% | 0.5 | -70.6% | 42.6% | 54 | 3.0% |
| 4 | Heikin-Ashi Trend ✓ | Daily | 13.5% | 0.5 | -65.1% | 45.3% | 1233 | 4.0% |
| 5 | Donchian Breakout | Weekly | 11.5% | 0.5 | -69.2% | 45.0% | 20 | 1.3% |
| 6 | EMA 50/200 Cross | Daily | 11.6% | 0.49 | -69.9% | 60.0% | 15 | 2.1% |
| 7 | ADX / DMI ✓ | Daily | 11.1% | 0.48 | -67.5% | 44.4% | 171 | 1.6% |
| 8 | Rate of Change ✓ | Weekly | 11.6% | 0.48 | -72.6% | 43.6% | 78 | 1.4% |
| 9 | EMA-10 Trend ✓ | Weekly | 11.5% | 0.46 | -80.5% | 47.6% | 103 | 1.3% |
| 10 | SMA 50/200 Cross | Daily | 10.0% | 0.44 | -84.6% | 50.0% | 16 | 0.5% |
| 11 | Donchian Breakout ✓ | Daily | 10.2% | 0.44 | -63.8% | 43.0% | 100 | 0.7% |
| 12 | Bollinger Breakout ✓ | Weekly | 9.3% | 0.44 | -52.6% | 44.0% | 25 | -0.9% |
| 13 | RSI Trend (>50) ✓ | Daily | 9.3% | 0.42 | -76.0% | 38.8% | 325 | -0.2% |
| 14 | MACD ✓ | Weekly | 9.4% | 0.42 | -71.6% | 48.9% | 47 | -0.8% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Align Technology (ALGN), RSI Trend (>50) on the weekly timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.